Skip to main content
Back
Watch Compare

MACROGENICS INC

Data quality: 100%
MGNX
NASDAQ Manufacturing Chemicals
$3.60
▲ $0.16 (4.65%)
Mkt Cap: 217.68 M
Price
$3.43
Mkt Cap
217.68 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 17.87% annually over 5 years — strong growth
Negative free cash flow of -82.95 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 18.18%
Capital efficient — spends only 1.28% of revenue on capex

Growth

Revenue Growth (5Y)
17.87%
Above sector avg (1.82%)
Revenue (1Y)-0.31%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-131.35%
Below sector avg (-54.01%)
ROIC-26.60%
Net Margin-49.91%
Op. Margin-48.72%

Safety

Debt / Equity
N/A
Current Ratio5.22
Interest Coverage-8.56

Valuation

PE (TTM|NTM)
-2.92 | -3.71
Below sector avg (-1.49)
P/B Ratio3.25
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -2.9 -1.5
P/B 3.3 1.6
ROE % -131.4 -54.0
Net Margin % -49.9 -41.5
Rev Growth 5Y % 17.9 1.8
D/E — 0.3

Analyst Price Target

5 analysts
Hold
Current
$3.60
+0.0%
Target
$3.60
$2.00
$4.00
$5.00
Forecast
Forward P/E -3.71
Forward EPS -$0.97
Est. Revenue 98.59 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.97
-$0.97 – -$0.97
 98.59 M 1
FY2026 -$1.73
-$2.45 – -$1.00
 88.32 M 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.02 -$0.22 -1000.0%
Q32025 -$0.51 $0.27 +153.5%
Q22025 $0.38 -$0.57 -250.0%
Q12025 -$0.69 -$0.65 +5.8%

ETFs Holding This Stock

CNCR CNCR
1.26% weight
BRSIX BRSIX
0.13% weight
DLRHX DLRHX
0.10% weight
DLHIX DLHIX
0.10% weight
DLHAX DLHAX
0.10% weight
GSCYX GSCYX
0.01% weight
GSCZX GSCZX
0.01% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -0.31% Revenue Growth (3Y) 59.52%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 17.87% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 149.50 M Net Income (TTM) -74.62 M
ROE -131.35% ROA -28.91%
Gross Margin N/A Operating Margin -48.72%
Net Margin -49.91% Free Cash Flow (TTM) -82.95 M
ROIC -26.60% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.22
Interest Coverage -8.56 Asset Turnover 0.58
Working Capital 187.62 M Tangible Book Value 67.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.92 Forward P/E -3.71
P/B Ratio 3.25 P/S Ratio 1.46
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 2.21 Fwd Earnings Yield N/A
FCF Yield -38.11%
Market Cap 217.68 M Enterprise Value 137.55 M
Per Share
EPS (Diluted TTM) -1.18 Revenue / Share 2.35
FCF / Share -1.31 OCF / Share -1.28
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.28% FCF Conversion 111.17%
SBC-Adj. FCF -100.55 M Growth Momentum -18.18

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 149.50 M 149.96 M 58.75 M 151.94 M 77.45 M
Net Income -74.62 M -66.97 M -9.06 M -119.76 M -202.12 M
EPS (Diluted) -1.18 -1.07 -0.15 -1.95 —
Gross Profit — — — — —
Operating Income -72.84 M -110.58 M -168.24 M -121.42 M -202.80 M
EBITDA — — — — —
R&D Expenses 147.17 M 177.19 M 166.58 M 207.03 M 214.58 M
SG&A Expenses — — — — —
D&A 7.17 M 7.54 M 9.65 M 11.87 M 11.26 M
Interest Expense 8.51 M 1.12 M 1.43 M — —
Income Tax -672,000.0 944,000.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 256.85 M 261.66 M 298.42 M 280.47 M 335.25 M
Total Liabilities 201.26 M 145.60 M 145.81 M 138.46 M 95.63 M
Shareholders' Equity 55.59 M 116.06 M 152.61 M 142.01 M 239.62 M
Total Debt — — — — —
Cash & Equivalents 57.22 M 182.84 M 100.96 M 108.88 M 123.47 M
Current Assets 219.94 M 217.49 M 251.34 M 222.18 M 279.56 M
Current Liabilities 43.12 M 55.53 M 56.11 M 48.61 M 74.58 M